Longevity isn't just aboutgroundbreaking scientific discoveries. It's also about the remarkable individuals propelling this field to new heights. The devoted researchers, entrepreneurs, and advocates committed to extending human life and healthspan.
Beneath you'll find some of the most inspiring personalities leading us to a longer and healthier life. If you're short on time to dive into their research, don't worry - I'll be showcasing their most significant work and insights in this blog. Both - the biohackingandradical life extension discoveries.
Marek Piotrowski
Longevity Advocate
George Church
A trailblazer in genetics and biotechnology, George Church is a renowned scientist whose work spans gene editing, synthetic biology, and genomic sequencing. A professor at Harvard Medical School and MIT, Church is an influential figure in the longevity industry due to his cutting-edge research and visionary outlook on the future of medicine. His pioneering work in CRISPR technology and the use of gene editing for disease prevention and reversal has opened up new avenues for life extension and health improvement.
David Sinclair is an acclaimed molecular biologist, researcher, and author who has made significant strides in the field of aging and longevity. With a keen focus on understanding the molecular mechanisms of aging, Sinclair's work has unveiled the potential of molecules like NAD+ and sirtuins in promoting health and longevity. He's a professor at Harvard Medical School and co-director of the Paul F. Glenn Center for the Biology of Aging. Sinclair's book, "Lifespan: Why We Age—and Why We Don't Have To," delves into the groundbreaking discoveries that are shaping our understanding of aging and life extension.
Nir Barzilai is the director of the Institute for Aging Research at the Albert Einstein College of Medicine. His research focuses on the genetics of exceptional longevity and the development of therapies targeting age-related diseases. He is also the founder of the TAME (Targeting Aging with Metformin) trial, which aims to test the potential of metformin to delay aging.
Ray Kurzweil, with a flair for the extraordinary, is a futurist, inventor, author, and visionary known for his trailblazing ideas and work in the longevity industry.He has contributed significantly to our understanding of the future of human health and life extension, dazzling us with his knack for prediction and innovation.
Kurzweil's expertise spans artificial intelligence, robotics, biotechnology, and life extension. He's authored several books, including "The Singularity Is Near" and "Transcend," which delve into the intersections of technology, health, and human potential. Ray's unique perspective on the fusion of biology and technology has earned him a reputation as a thought leader in the longevity space.
What makes Ray Kurzweil truly special is his unwavering belief in the power of human ingenuity and the potential for exponential growth in technology. He predicts that we'll soon witness a technological "singularity," where advances in AI, genetics, and nanotechnology will lead to radical life extension and the potential to reverse aging.
Laura Deming is the founder and managing partner of the Longevity Fund, a venture capital firm investing in companies focused on aging research and therapies. She is a passionate advocate for the development of treatments that can extend healthspan and address age-related diseases. Her fund supports startups working on innovative technologies and therapies in the longevity field.
Eric Verdin is a renowned scientist in the longevity field and serves as the President and CEO of the Buck Institute for Research on Aging. The Buck Institute is a leading research center dedicated to understanding the science behind aging and finding ways to extend the healthy years of life. Dr. Verdin's research focuses on the role of metabolism and diet in the aging process, particularly the effects of ketone bodies and calorie restriction on aging and age-related diseases.
Under his leadership, the Buck Institute has made significant strides in advancing our understanding of the molecular processes that contribute to aging. Dr. Verdin's work has contributed to the development of new therapies and strategies to promote healthy aging and combat age-related diseases. His passion for research and commitment to improving human health have made him a prominent figure in the longevity industry.
Aubrey de Grey is the President at Longevity Escape Velocity (LEV) Foundation and the co-founder and Chief Science Officer of SENS Research Foundation. He is a prominent researcher in the field of rejuvenation biotechnology, focusing on regenerative medicine approaches to combat age-related diseases. His work involves the development of therapies targeting the seven categories of cellular and molecular damage that accumulate with age.
Valter Longo is a distinguished biochemist and gerontologist whose research has revolutionized our understanding of nutrition and its impact on aging and longevity. As a professor at the University of Southern California, Longo's groundbreaking work on fasting-mimicking diets and the role of nutrition in cellular regeneration has shed light on how our eating habits influence our healthspan. His book, "The Longevity Diet," offers valuable insights into the optimal diet for promoting longevity and preventing age-related diseases.
Brian Kennedy is a distinguished professor at the Buck Institute for Research on Aging. His research focuses on understanding the genetic and molecular mechanisms of aging, with a particular interest in the nutrient-sensing TOR pathway. He is also the co-founder of the company UNITY Biotechnology, which develops senolytic therapies for age-related diseases.
Cynthia Kenyon is the Vice President of Aging Research at Calico Labs. She is a pioneer in the field of aging research, discovering the role of insulin and IGF-1 signaling pathways in aging using C. elegans as a model organism. Her work has laid the foundation for numerous studies exploring the molecular mechanisms of aging.
Elizabeth Blackburn is a Nobel laureate and professor at the University of California, San Francisco. She is a co-discoverer of telomerase, an enzyme that plays a crucial role in cellular aging and cancer. Her research focuses on understanding the role of telomeres and telomerase in aging, as well as developing potential interventions to maintain telomere health.
Judith Campisi is a professor at the Buck Institute for Research on Aging and a co-founder of UNITY Biotechnology. Her research focuses on understanding the role of cellular senescence in aging and age-related diseases, as well as developing potential interventions to reduce the impact of senescent cells. She is a leading expert on the biology of senescence and its implications for healthspan extension.
João Pedro de Magalhães is a senior lecturer at the University of Liverpool and the leader of the Integrative Genomics of Ageing Group. His research focuses on understanding the genetic and molecular mechanisms of aging, with an emphasis on comparative genomics and bioinformatics. He has developed several databases and resources related to aging research, including the Human Ageing Genomic Resources.
Peter Diamandis is a co-founder of Human Longevity Inc. and the founder of the XPRIZE Foundation. He is a visionary entrepreneur and thought leader focused on using technology and innovation to solve humanity's grand challenges, including aging. His work at Human Longevity Inc. is centered on leveraging genomic data, advanced imaging, and machine learning to develop personalized healthcare solutions.
Steve Horvath is a professor of human genetics and biostatistics at the University of California, Los Angeles. He is the creator of the "epigenetic clock," a widely used method for measuring biological age based on DNA methylation patterns. His research focuses on understanding the molecular mechanisms of aging and developing interventions to slow or reverse the aging process.
Peter Attia is a physician, health optimization expert, and advocate for a comprehensive, individualized approach to longevity. His passion for promoting health and well-being has led him to explore the interplay between nutrition, exercise, sleep, and stress management in the quest for optimal healthspan. Dr. Attia's experience as a medical doctor, endurance athlete, and researcher has given him unique insights into the various factors that contribute to a longer, healthier life.
Recently he published this book "Outlive. The Science & Art of Longevity"
An esteemed neuroscientist, Andrew Huberman has made significant contributions to our understanding of the nervous system and brain function. As a professor at Stanford University School of Medicine, Huberman's research focuses on brain health, stress, and the neural processes that impact our well-being. His work is particularly relevant to longevity, as he explores the brain's potential to adapt, regenerate, and recover from injury or disease.
Dr. Mark Hyman is a functional medicine physician, author, and host of "The Doctor's Farmacy" podcast. He focuses on the role of nutrition and lifestyle in promoting health, well-being, and longevity. Dr. Hyman advocates for a systems-based approach to health, emphasizing the importance of addressing the root causes of chronic disease and age-related conditions.
Ben Greenfield is a fitness expert, biohacker, and host of the "Ben Greenfield Fitness" podcast. He explores various strategies for optimizing human performance, health, and longevity, including nutrition, exercise, and cutting-edge technologies. Ben also shares his personal experiments and experiences with biohacking and healthspan extension.
Longevity is an amazing and broad concept that starts to inspire more and more people around the world. It has many layers, many directions. But the overall concept is about — living longer an active and healthy life. A long lifespan and healthspan combined.
Become
LongevityInsider
Sign-up for my mailing list today, and receive the latest biohacking tech, gear, and tips.
